Su-Min Park

4PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 17, 2024
Evaluation serum soluble interleukin 2 receptor with diagnosis and prognosis in canine solid tumour: 34 cases.

Hyun NamKung, Su-Min Park, Jae-Hyeon Im

|Feb 04, 2024
In vitro evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines.

Hye-Gyu Lee, Ga-Hyun Lim, Ju-Hyun An

|Aug 02, 2023
Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE2 activation.

Kyeongbo Kim, Ju-Hyun An, Su-Min Park

|Mar 28, 2021
Feline adipose tissue-derived mesenchymal stem cells pretreated with IFN-γ enhance immunomodulatory effects through the PGE₂ pathway.

Seol Gi Park, Ju Hyun An, Qiang Li

Pageof 1

Frequent Collaborators

4 joint publications

Hwa-Young Youn

3 joint publications

Ju-Hyun An

3 joint publications

GaHyun Lim

3 joint publications

Kyung-Won Seo